240 related articles for article (PubMed ID: 28214926)
41. Different distributions of hepatitis C virus genotypes among HIV-infected patients with acute and chronic hepatitis C according to interleukin-28B genotype.
Neukam K; Nattermann J; Rallón N; Rivero A; Caruz A; Macías J; Vogel M; Benito J; Camacho A; Mira J; Schwarze-Zander C; Barreiro P; Martínez A; Rockstroh J; Soriano V; Pineda J
HIV Med; 2011 Sep; 12(8):487-93. PubMed ID: 21375685
[TBL] [Abstract][Full Text] [Related]
42. Predicting response to therapy in chronic hepatitis C: an approach combining interleukin-28B gene polymorphisms and clinical data.
Ladero JM; Martin EG; Fernández C; Carballo M; Devesa MJ; Martínez C; Suárez A; Díaz-Rubio M; Agúndez JA
J Gastroenterol Hepatol; 2012 Feb; 27(2):279-85. PubMed ID: 21722179
[TBL] [Abstract][Full Text] [Related]
43. Importance of IL28B gene polymorphisms in hepatitis C virus genotype 2 and 3 infected patients.
Sarrazin C; Susser S; Doehring A; Lange CM; Müller T; Schlecker C; Herrmann E; Lötsch J; Berg T
J Hepatol; 2011 Mar; 54(3):415-21. PubMed ID: 21112657
[TBL] [Abstract][Full Text] [Related]
44. Association of interleukin-28B rs12979860 and rs8099917 polymorphisms with sustained viral response in hepatitis C virus genotype 1 and 3 infected patients from the Indian subcontinent.
Ranjan P; Fletcher GJ; Radhakrishnan M; Sivakumar J; Premkumar PS; Goel A; Zachariah UG; Abraham P
Indian J Med Microbiol; 2016; 34(3):335-41. PubMed ID: 27514956
[TBL] [Abstract][Full Text] [Related]
45. IFNL3 (IL28B) and IFNL4 polymorphisms are associated with treatment response in Thai patients infected with HCV genotype 1, but not with genotypes 3 and 6.
Akkarathamrongsin S; Thong VD; Payungporn S; Poovorawan K; Prapunwattana P; Poovorawan Y; Tangkijvanich P
J Med Virol; 2014 Sep; 86(9):1482-90. PubMed ID: 24782280
[TBL] [Abstract][Full Text] [Related]
46. Profound week 4 interferon responsiveness is mandatory for hepatitis C genotype 1 patients with unfavorable IL-28B genotype.
Huang CF; Yu ML; Kao JH; Tseng TC; Yeh ML; Huang JF; Dai CY; Lin ZY; Chen SC; Wang LY; Juo SH; Chuang WL; Liu CH
J Clin Virol; 2013 Apr; 56(4):293-8. PubMed ID: 23246359
[TBL] [Abstract][Full Text] [Related]
47. Interleukin 28B gene polymorphisms in hepatitis C virus-related cryoglobulinemic vasculitis.
Sansonno D; Russi S; Serviddio G; Conteduca V; D'Andrea G; Sansonno L; Pavone F; Lauletta G; Mariggiò MA; Dammacco F
J Rheumatol; 2014 Jan; 41(1):91-8. PubMed ID: 24293567
[TBL] [Abstract][Full Text] [Related]
48. IL28B genetic variation and treatment response in patients with hepatitis C virus genotype 3 infection.
Moghaddam A; Melum E; Reinton N; Ring-Larsen H; Verbaan H; Bjøro K; Dalgard O
Hepatology; 2011 Mar; 53(3):746-54. PubMed ID: 21374656
[TBL] [Abstract][Full Text] [Related]
49. High resolution melting curve assay for detecting rs12979860 IL28B polymorphisms involved in response of Iranian patients to chronic hepatitis C treatment.
Fateh A; Aghasadeghi MR; Keyvani H; Mollaie HR; Yari S; Hadizade Tasbiti AR; Ghazanfari M; Monavari SH
Asian Pac J Cancer Prev; 2015; 16(5):1873-80. PubMed ID: 25773839
[TBL] [Abstract][Full Text] [Related]
50. Relationship between the genetic variation in interleukin 28B and response to antiviral therapy in patients with chronic hepatitis C.
Xie JQ; Guo XY; Zhang XH; Lin BL; Xie DY; Gao ZL; Wang GS; Zhao ZX
Chin Med J (Engl); 2012 Jul; 125(13):2334-8. PubMed ID: 22882858
[TBL] [Abstract][Full Text] [Related]
51. Interferon-λ polymorphisms and response to pegylated interferon in Iranian hepatitis C patients.
Haj-Sheykholeslami A; Keshvari M; Sharafi H; Pouryasin A; Hemmati K; Mohammadzadehparjikolaei F
World J Gastroenterol; 2015 Aug; 21(29):8935-42. PubMed ID: 26269684
[TBL] [Abstract][Full Text] [Related]
52. Interleukin-28B gene non-TT allele strongly predicts treatment failure for genotype 1 infected chronic hepatitis C patients with advanced fibrosis: a case control study.
Hu CC; Lin CL; Chang LC; Chien CH; Chen LW; Liu CJ; Chien RN
BMC Infect Dis; 2015 Mar; 15():156. PubMed ID: 25888020
[TBL] [Abstract][Full Text] [Related]
53. CCL4 is the only predictor for non-responder in GT-1 CHC patients with favorable IL28B genotype when treated with PegIFN/RBV.
Lin CC; Su SH; Jeng WJ; Huang CH; Teng W; Chen WT; Chen YC; Lin CY; Sheen IS
BMC Gastroenterol; 2017 Dec; 17(1):169. PubMed ID: 29284412
[TBL] [Abstract][Full Text] [Related]
54. Polymorphism of the IL28B gene (rs8099917, rs12979860) and virological response of Pakistani hepatitis C virus genotype 3 patients to pegylated interferon therapy.
Aziz H; Raza A; Ali K; Khattak JZ; Irfan J; Gill ML
Int J Infect Dis; 2015 Jan; 30():91-7. PubMed ID: 25462177
[TBL] [Abstract][Full Text] [Related]
55. Association of interleukin-28B genotype and hepatocellular carcinoma recurrence in patients with chronic hepatitis C.
Hodo Y; Honda M; Tanaka A; Nomura Y; Arai K; Yamashita T; Sakai Y; Yamashita T; Mizukoshi E; Sakai A; Sasaki M; Nakanuma Y; Moriyama M; Kaneko S
Clin Cancer Res; 2013 Apr; 19(7):1827-37. PubMed ID: 23426277
[TBL] [Abstract][Full Text] [Related]
56. Distribution of interferon lambda-3 gene polymorphisms in Australian patients with previously untreated genotype 1 chronic hepatitis C: Analysis from the PREDICT and CHARIOT studies.
Roberts SK; Mitchell J; Leung R; Booth D; Bollipo S; Ostapowicz G; Sloss A; McCaughan GW; Dore GJ; Thompson A; Crawford DH; Sievert W; Weltman M; Cheng W; George J;
J Gastroenterol Hepatol; 2014 Jan; 29(1):179-84. PubMed ID: 24219707
[TBL] [Abstract][Full Text] [Related]
57. IL28B genetic variation is associated with spontaneous clearance of hepatitis C virus, treatment response, serum IL-28B levels in Chinese population.
Shi X; Pan Y; Wang M; Wang D; Li W; Jiang T; Zhang P; Chi X; Jiang Y; Gao Y; Zhong J; Sun B; Xu D; Jiang J; Niu J
PLoS One; 2012; 7(5):e37054. PubMed ID: 22649509
[TBL] [Abstract][Full Text] [Related]
58. Regulatory polymorphism of CXCL10 rs1439490 in seronegative occult hepatitis C virus infection.
Wang X; Wang S; Liu ZH; Qi WQ; Zhang Q; Zhang YG; Sun DR; Xu Y; Wang HG; Li ZX; Cong XL; Zhao P; Zhou CY; Wang JB
World J Gastroenterol; 2018 May; 24(20):2191-2202. PubMed ID: 29853737
[TBL] [Abstract][Full Text] [Related]
59. Association between CXCL10 and DPP4 Gene Polymorphisms and a Complementary Role for Unfavorable IL28B Genotype in Prediction of Treatment Response in Thai Patients with Chronic Hepatitis C Virus Infection.
Thanapirom K; Suksawatamnuay S; Sukeepaisarnjaroen W; Tangkijvanich P; Treeprasertsuk S; Thaimai P; Wasitthankasem R; Poovorawan Y; Komolmit P
PLoS One; 2015; 10(9):e0137365. PubMed ID: 26339796
[TBL] [Abstract][Full Text] [Related]
60. Prevalence and clinical implications of IL28B genotypes in Taiwanese patients with chronic hepatitis C.
Mah YH; Liu CH; Chen CL; Tseng TC; Liu CJ; Chen PJ; Chen DS; Kao JH
J Formos Med Assoc; 2016 Nov; 115(11):953-960. PubMed ID: 27751759
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
